ARCHIVES

Study Suggests Biomarker For Resistance to Tamoxifen

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

April 26, 2013

FDA Approves 35 Medicines In Fiscal 2012, Eight in Cancer

December 28, 2012

NCI Programs: Unequal Outcomes For Minorities The Result of Unequal Treatment NCI Suggests Awareness Campaign

December 17, 1999

NCI, FDA Make Progress On Some Issues, Bu Differences Remain On Endpoints

November 10, 1989

DCT Board Approves Concepts For Acoustic Microscopy, Taxol Development, AIDS R&D

June 15, 1990

NCI Pulls Back Curtain on “Zone of Uncertainty” — Funding Patterns Released With Little Comment

May 4, 2012